Boehringer Ingelheim: Pharmaceutical giant will also produce in Shanghai in the future
Boehringer Ingelheim has been active in China for 30 years. The German company will now produce one of its best-selling products, the diabetes drug Trajenta, in Shanghai.
14. October 2025
14. October 2025
Last updated: 14. October 2025
Share article: